FEMASYS INC

FEMYSEC EDGAR

Surgical & Medical Instruments & Apparatus(DE)CIK: 1339005

Concept	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$1.1M	$1.2M	$1.2M	$1.0M
Cost of Goods and Services Sold	$380.1K	$441.9K	$370.4K	$306.5K
Gross Profit	—	—	$809.3K	$731.4K
Research and Development Expense	$7.2M	$5.8M	$4.1M	$4.1M
Operating Expenses	$15.2M	$12.4M	$9.1M	$7.7M
Operating Income (Loss)	-$14.5M	-$11.6M	-$8.3M	-$6.9M
Interest Expense	—	$13.5K	$19.2K	$12.6K
Nonoperating Income (Expense)	$265.6K	$212.4K	$803.0K	$20.0K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

Concept	FY2024	FY2023	FY2022	FY2021
Assets	$27.8M	$16.9M	$28.6M	$7.6M
Assets, Current	$23.2M	$14.1M	$25.6M	$3.9M
Cash and Cash Equivalents, at Carrying Value	$21.7M	$13.0M	$24.8M	$3.3M
Accounts Receivable, after Allowance for Credit Loss, Current	$98.9K	$77.5K	$84.3K	$125.8K
Inventory, Net	$667.1K	$436.7K	$208.3K	$131.4K
Liabilities	$9.4M	$1.7M	$2.2M	$4.1M
Liabilities, Current	$3.1M	$1.5M	$1.7M	$2.9M
Accounts Payable, Current	$1.1M	$510.8K	$445.5K	$674.3K
Stockholders' Equity Attributable to Parent

Concept	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$11.3M	-$10.7M	-$7.9M	-$4.9M
Net Cash Provided by (Used in) Investing Activities	-$143.9K	-$407.5K	-$306.9K	$968.3K
Net Cash Provided by (Used in) Financing Activities	$20.2M	-$681.6K	$29.7M	$871.6K
Payments to Acquire Property, Plant, and Equipment	$143.9K	$407.5K	$306.9K	$8.4K
Payments for Repurchase of Common Stock	$230.0K	$0.00	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)